Highlights ■ A-IPF can be used as a biomarker for platelet engraftment after hematopoietic stem cell transplantation. ■ IPF% and IRF% are not reliable biomarkers for bone marrow engraftment after hematopoietic stem cell transplantation. ■ IPF%, A-IPF, and IRF% do not support safe reduction of prophylactic platelet transfusions. ■ Cellular immaturity parameters lack standardized quality control measures for harmonization between clinical and research laboratories. ABSTRACT Objective: This study aimed to evaluate relative immature platelet fraction (IPF%), absolute immature platelet fraction […]
